Clinical Trial Update: A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients. [Phase 2]

View source ↗

Summary

A Phase 2, controlled study evaluated the combination of fenofibrate and metformin for weight loss and weight loss maintenance in obese patients; the trial has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• metformin (metformin)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Obesity | Phase 2 | Status: COMPLETED